Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
K2M, Inc. Market Share Analysis
Publication Date Oct 2012
Publisher GlobalData
Product Type Report
Pages 50
Single User License $ 1000.00
Site User License $ 2000.00
Corporate User License $ 3000.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

K2M, Inc. Market Share Analysis

Summary

GlobalData’s new report, “K2M, Inc. Market Share Analysis” provides in-depth information on K2M, Inc..’s market position in the spinal surgery market. The report also provides data and information on the overall competitive landscape within the spinal surgery market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the spinal surgery market.
- K2M, Inc..’s company shares (in Revenues) information for all the key countries the company has presence in –Australia, United Kingdom, Germany, Spain, United States and Canada.
- K2M, Inc..’s company shares (in Revenues) information for the spinal surgery market.
- All the key data-points are for 2011 and cover all the key regions – North America, Europe and Asia-Pacific.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, K2M, Inc..’s operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to K2M, Inc..’s market positions.


Companies Mentioned

Medtronic, Inc. DePuy Synthes Companies Synthes, Inc. Stryker Corporation NuVasive, Inc. Orthofix International N.V. Zimmer Holdings, Inc. Globus Medical, Inc. Alphatec Holdings, Inc. B. Braun Melsungen AG Pioneer Surgical Technology, Inc. Biomet, Inc. DJO Finance LLC China Kanghui Holdings MEDICREA INTERNATIONAL Solco Biomedical Co., Ltd. Japan Medical Dynamic Marketing, Inc. Trauson Holdings Company Limited Korea Bone Bank Inc. U&I Corporation Sushrut Surgicals Private Limited Bonovo Orthopedics, Inc. Gs Medical Co.,Ltd. ArthroCare Corporation Taeyeon Medical CO.,LTD

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
3 Definitions of Markets/Categories Covered 7
3.1 Orthopedic Devices 7
3.1.1 Spinal Surgery 7
4 Company Snapshot 8
4.1 Key Information 8
4.2 Company Overview 8
4.3 Major Products and Services 9
4.3.1 Overview 9
5 Competitors 10
6 Competitive Landscape 11
6.1 Orthopedic Devices (Spinal Surgery), Global, Market Share (%), 2011 11
6.2 K2M, Inc., Orthopedic Devices(Spinal Surgery), by Region, Market Share (2011) 13
6.3 K2M, Inc., Orthopedic Devices(Spinal Surgery), by Country, Market Share (2011) 14
7 Key Employees 16
8 Locations And Subsidiaries 17
8.1 Head Office 17
8.2 Other Locations & Subsidiaries 17
9 Financial Deals Landscape 18
9.1 K2M, Inc., Deals Volume Summary, 2006 to YTD 2012 18
10 K2M, Inc. Detailed Deal Summary 20
10.1 Asset Purchase 20
10.1.1 K2M Acquires Worldwide Rights To Injectable Polymer Technology From Promethean Surgical Devices 20
10.2 Venture Financing 22
10.2.1 K2M Secures $21.5 Million In Mezzanine Funding Round 22
10.3 Private Equity 24
10.3.1 Welsh, Carson anderson & Stowe Completes Acquisition Of Majority Stake In K2M 24
10.4 Partnerships 25
10.4.1 K2M Enters Into Licensing Agreement With Amendia 25
10.4.2 K2M Enters Into Technology Integration Agreement With Cadwell Labs 26
10.4.3 K2M Enters Into Agreement With Smith & Nephew 27
11 Recent Developments 28
11.1 Strategy And Business Planning 28
11.1.1 Oct 14, 2008: K2M Enters Biomaterials Sector Of The Spinal Market 28
11.2 Corporate Communications 28
11.2.1 Dec 13, 2011: K2M Appoints Don O’Hearn As Senior Vice President Of Sales 28
11.2.2 Oct 18, 2011: K2M Announces Three New Senior International Appointments 29
11.2.3 Oct 07, 2008: K2M Appoints Gregory Cole As New CFO 29
11.3 Product News 30
11.3.1 Sep 05, 2012: K2M Launches Serengeti Complex Spine Minimally Invasive Retractor System At Scoliosis Research Society 47th Annual Meeting 30
11.3.2 Aug 16, 2012: K2M Strengthens Minimally Invasive Spine Portfolio With Announcement Of Neuromonitoring Technology At 2012 WCMISST Conference 30
11.3.3 Jul 17, 2012: K2M To Debut Rail 4D Technology At 19th IMAST 31
11.3.4 Mar 01, 2012: K2M Receives FDA 510(k) Clearance For Its SANTORINI Corpectomy Cage Systems 31
11.3.5 Nov 03, 2011: K2M Announces Global Launch Of CHESAPEAKE Anterior-Lumbar Stabilization System At 2011 NASS Annual Meeting 32
11.3.6 Nov 02, 2011: K2M Announces Global Launch Of EVEREST Degenerative Spinal System At 2011NASS Annual Meeting 32
11.3.7 Nov 01, 2011: K2M Announces Technology Acquisition And Debut Of BLUE RIDGE Hybrid Cervical Plate System At NASS 2011 Annual Meeting 33
11.3.8 Oct 04, 2011: K2M Launches CHESAPEAKE Cervical-Ti Stabilization System At 2011 CNS 33
11.3.9 Oct 04, 2011: K2M Launches PYRENEES Translational Cervical Plate System At 2011 CNS 34
11.3.10 Apr 27, 2011: K2M Receives FDA 510(k) Approval For EVEREST Degenerative Spinal System 34
11.3.11 Mar 15, 2011: K2M Receives CE Mark For RAVINE Lateral Access System And ALEUTIAN Lateral Interbody System 34
11.3.12 Oct 06, 2010: K2M Debuts RAVINE Lateral Access System At NASS Annual Conference 35
11.3.13 Oct 01, 2010: K2M Launches VIKOS Cervical Allograft System 35
11.3.14 Sep 07, 2010: K2M Receives 510(k) Clearance For CHESAPEAKE Anterior-Lumbar Stabilization System 35
11.3.15 Nov 11, 2009: K2M Launches TERRA NOVA Minimally Invasive Access System And The SERENGETI Disposable Kit At NASS Annual Conference 36
11.3.16 Nov 03, 2009: K2M Gets PMDA Clearance For Its MESA Spinal System 36
11.3.17 Sep 15, 2009: K2M Releases NATURAL BRIDGE LP Transverse Connectors For Stabilization Of Thoracolumbar Spine 37
11.3.18 Jun 30, 2009: K2M Introduces CASPIAN Spinal System To Address Treatment For Cervico-Thoracic Pathologies 37
11.3.19 Mar 10, 2009: K2M Announces FDA 510(K) And CE Mark Approval For CASPIAN Spinal System 38
11.3.20 Jan 27, 2009: K2M Announces International Launch Of POTOMAC And SERENGETI Spinal Systems 38
11.3.21 Jul 22, 2008: K2M Launches RANGE Rigid Rod For Complex Procedures 39
11.3.22 Mar 03, 2008: K2M Launches ALEUTIAN Anterior - Lumbar Spacer Systems 39
11.3.23 Oct 24, 2007: K2M Launches SERENGETI Minimally Invasive Retractor System 39
11.3.24 Oct 09, 2007: K2M Announces Phase II Launch Of PYRENEES Cervical Plate System 40
11.3.25 Jun 26, 2007: K2M Announces The RANGE Spinal System For Complex Spine Cases 40
11.4 Product Approvals 41
11.4.1 Mar 01, 2012: K2M Receives FDA 510(k) Clearance For Its SANTORINI Corpectomy Cage Systems 41
11.4.2 Apr 27, 2011: K2M Receives FDA 510(k) Approval For EVEREST Degenerative Spinal System 41
11.4.3 Mar 15, 2011: K2M Receives CE Mark For RAVINE Lateral Access System And ALEUTIAN Lateral Interbody System 42
11.4.4 Mar 15, 2011: K2M Receives CE Mark For RAVINE Lateral Access System And ALEUTIAN Lateral Interbody System 42
11.4.5 Sep 07, 2010: K2M Receives 510(k) Clearance For CHESAPEAKE Anterior-Lumbar Stabilization System 43
11.4.6 Nov 03, 2009: K2M Gets PMDA Clearance For Its MESA Spinal System 43
11.4.7 Mar 10, 2009: K2M Announces FDA 510(K) And CE Mark Approval For CASPIAN Spinal System 44
12 Appendix 45
12.1 Research Methodology 46
12.2 Secondary Research 46
12.3 Primary Research 47
12.4 Models 47
12.5 Forecasts 47
12.6 Expert Panels 48
12.7 GlobalData Consulting 48
12.8 Currency Conversion 49
12.9 Contact Us 50
12.10 Disclaimer 50

List of Tables
1.1 List of Tables
Table 1: K2M, Inc., Key Information, 2011 8
Table 2: Orthopedic Devices (Spinal Surgery), Global, Company Share by Revenue ($m), 2011 12
Table 3: K2M, Inc., Orthopedic Devices (Spinal Surgery), by Region, Revenue ($m) and Market Share (%), 2011 13
Table 4: K2M, Inc., Orthopedic Devices (Spinal Surgery), by Country, Revenue ($m) and Market Share (%), 2011 15
Table 5: K2M, Inc., Key Employees 16
Table 6: K2M, Inc., Other Locations 17
Table 7: K2M, Inc., Deals Volume Summary, 2006 to YTD 2012 18
Table 8: K2M, Inc., Deals Summary, 2006 to YTD 2012 19
Table 9: K2M Acquires Worldwide Rights To Injectable Polymer Technology From Promethean Surgical Devices 20
Table 10: K2M Secures $21.5 Million In Mezzanine Funding Round 22
Table 11: Welsh, Carson anderson & Stowe Completes Acquisition Of Majority Stake In K2M 24
Table 12: K2M Enters Into Licensing Agreement With Amendia 25
Table 13: K2M Enters Into Technology Integration Agreement With Cadwell Labs 26
Table 14: K2M Enters Into Agreement With Smith & Nephew 27
Table 15: USD to Local Currency, Average Exchange Rate, 2011 49

List of Figures
1.2 List of Figures
Figure 1: Orthopedic Devices (Spinal Surgery), Global, Market Share (%), 2011 11
Figure 2: K2M, Inc., Orthopedic Devices (Spinal Surgery), by Region, Market Share (%), 2011 13
Figure 3: K2M, Inc., Orthopedic Devices (Spinal Surgery), by Country, Market Share (%), 2011 14
Figure 4: K2M, Inc., Deals Volume Summary, 2006 to YTD 2012 18

Title Date Price
3DM Inc. - Strategic SWOT Analysis Review
By GlobalData
3DM Inc. - Strategic SWOT Analysis ReviewSummary3DM Inc. (3DM) is a privately held specialty biomaterials and medical device company. It is a subsidiary of 3D-Matrix, Ltd, Japan. The company develops ...Read More
Aug 2011 $125.00
3M Health Care - Strategic SWOT Analysis Review
By GlobalData
3M Health Care - Strategic SWOT Analysis ReviewSummary3M Health Care, a business segment of 3M Company, provides medical and oral care products, drug delivery and health information systems worldwide. ...Read More
Aug 2011 $125.00
3WIN nv - Product Pipeline Analysis
By GlobalData
3WIN nv - Product Pipeline AnalysisSummary3WIN nv (3WIN) is engaged in the development and marketing of active implantable medical devices. The company is developing a deep brain stimulator (DBS), whi ...Read More
Oct 2011 $750.00
4SC AG (VSC) - Financial and Strategic SWOT Analysis Review
By GlobalData
4SC AG (VSC) - Financial and Strategic SWOT Analysis ReviewSummary4SC AG is a Germany based research oriented company which concentrates mainly on the discovery of the drugs as well as its development ...Read More
Aug 2011 $125.00
A&G Pharmaceutical, Inc. - Product Pipeline Analysis
By GlobalData
SummaryA&G Pharmaceutical, Inc. (A&G) is a pharmaceutical company, based in the US. The company develops therapeutic and diagnostic products for the in-vitro diagnostic markets. Its products include b ...Read More
Nov 2012 $750.00
A-dec Inc. GmbH Market Share Analysis
By GlobalData
A-dec Inc. GmbH Market Share AnalysisSummaryGlobalData’s new report, “A-dec Inc. GmbH Market Share Analysis” provides in-depth information on A-dec Inc..’s market position in the dental device ...Read More
Jan 2013 $1000.00
A.P. Pharma, Inc. (APPA) - Financial and Strategic SWOT Analysis Review
By GlobalData
A.P. Pharma, Inc. (APPA) - Financial and Strategic SWOT Analysis ReviewSummaryA.P. Pharma, Inc. (AP Pharma) is a publicly held research focused specialty pharmaceutical company engaged in the developm ...Read More
Aug 2011 $125.00
AAIPharma Inc.: SWOT Analysis & Company Profile
By Business Review
This SWOT Analysis company profile is a crucial resource for industry executives and anyone looking to quickly understand the key information concerning AAIPharma Inc.’s business.Business Review’s ...Read More
Nov 2010 $99.00
AAIPharma Services Corporation - Strategy and SWOT Report
By MarketLine
AAIPharma Services Corporation’s SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT ...Read More
Jun 2011 $125.00
AAIPharma Services Corporation - SWOT Analysis
By MarketLine
AAIPharma Services Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. AAIPharma Services Corporation - SWOT Analysis examines the company� ...Read More
Jun 2012 $150.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   
   
For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9425069161
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z